Health Condition 1: C189- Malignant neoplasm of colon, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Dr Reddys Laboratories
Eligibility
Inclusion criteria
Inclusion criteria: ? Metastatic adenocarcinoma of colon or rectum ? Inoperable and eligible for first line systemic therapy ? Age = 18yrs. ? Signed informed consent.
Exclusion criteria
Exclusion criteria: ? Any participants who received his or her treatment at participating study sites prior to enrolment except for patients with metachronous mCRC ? Non-metastatic Colorectal cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To understand the clinical profile (e.g. Baseline demographics, Clinical presentations, co-morbid conditions, Performance status etc.) of Metastatic Colorectal cancer (mCRC) patients undergoing treatment ? To understand the tumour characteristics (tumour location, Site of metastasis, Number of metastatic sites, Molecular profile [KRAS including KRAS G12C, BRAF, MSI/MSS, HER2 etc) of Metastatic Colorectal cancer (mCRC) patients undergoing treatment. ? To understand the current treatment pattern of Metastatic Colorectal cancer (mCRC) patients ? To understand Treatment outcomes in Metastatic Colorectal cancer (mCRC) patients undergoing treatmentTimepoint: Baseline(Day 0), Follow up (3-6 months), follw up (12-18 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Rahul Rathod
Dr Reddys Laboratories Ltd
Outcome results
None listed